![]() Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | ![]() Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | ![]() Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2003 | Founding Date 2015 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Vancouver, CA HQ Seattle, US | Locations San Diego, US HQ Dublin 2, IE | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 45519% increase | Employees 11820% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) 973.3 m | Valuation ($) 208 m | Valuation ($) 452 m |
Financial | |||
Revenue (est.) | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($81.1m) (FY, 2025) | Net income ($170.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 125.9m | Total funding raised $ 480m | Total funding raised $ 50m |

Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company